MSB 2.51% 97.0¢ mesoblast limited

Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients, page-2

  1. 101 Posts.
    lightbulb Created with Sketch. 28
    https://hotcopper.com.au/data/attachments/2080/2080636-01d11f4e6af2e1cbfbd1f77b55c11aef.jpg
    Should go nuts now smile.png
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.